Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ford

Showing results (401-410 of 568) with videos related to

Pageof 57
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 20, 2011
Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgeryK E Rollins, C J Peters, P M Safranek, et al.
The Journal of Behavioral Health Services & Research|January 28, 2012
Improving quality of care in substance abuse treatment using five key process improvement principlesKim A Hoffman, Carla A Green, James H Ford, et al.
Transcultural Psychiatry|June 6, 2024
Impact of a psychoeducational intervention on willingness to seek help for depression among African American young adultsBenita A Bamgbade, Jamie C Barner, Carolyn M Brown, et al.
Frontiers in Neurology|June 22, 2026
Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a <i>post hoc</i> analysis from a phase 3 migraine prevention studyChristian Lampl, Richard B Lipton, Sarah Lipsius, et al.
Journal of Patient-Reported Outcomes|July 13, 2019
Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcomeRebecca M Speck, Huda Shalhoub, David W Ayer, et al.
Headache|August 15, 2018
Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With GalcanezumabDavid W Ayer, Vladimir Skljarevski, Janet H Ford, et al.
Patient Preference and Adherence|December 7, 2018
Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraineJanet H Ford, Shonda A Foster, Virginia L Stauffer, et al.
JMIR Research Protocols|February 12, 2020
Willingness to Seek Help for Depression in Young African American Adults: Study ProtocolBenita A Bamgbade, Jamie C Barner, Kentya H Ford, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 18, 2020
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label studyJanet H Ford, Virginia L Stauffer, Peter McAllister, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 19, 2020
Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label studyJanet H Ford, Virginia L Stauffer, Peter McAllister, et al.
Pageof 57

Showing results (401-410 of 568) with videos related to

Sort By:
Pageof 57
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 20, 2011
Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgeryK E Rollins, C J Peters, P M Safranek, et al.
The Journal of Behavioral Health Services & Research|January 28, 2012
Improving quality of care in substance abuse treatment using five key process improvement principlesKim A Hoffman, Carla A Green, James H Ford, et al.
Transcultural Psychiatry|June 6, 2024
Impact of a psychoeducational intervention on willingness to seek help for depression among African American young adultsBenita A Bamgbade, Jamie C Barner, Carolyn M Brown, et al.
Frontiers in Neurology|June 22, 2026
Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a <i>post hoc</i> analysis from a phase 3 migraine prevention studyChristian Lampl, Richard B Lipton, Sarah Lipsius, et al.
Journal of Patient-Reported Outcomes|July 13, 2019
Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcomeRebecca M Speck, Huda Shalhoub, David W Ayer, et al.
Headache|August 15, 2018
Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With GalcanezumabDavid W Ayer, Vladimir Skljarevski, Janet H Ford, et al.
Patient Preference and Adherence|December 7, 2018
Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraineJanet H Ford, Shonda A Foster, Virginia L Stauffer, et al.
JMIR Research Protocols|February 12, 2020
Willingness to Seek Help for Depression in Young African American Adults: Study ProtocolBenita A Bamgbade, Jamie C Barner, Kentya H Ford, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 18, 2020
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label studyJanet H Ford, Virginia L Stauffer, Peter McAllister, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 19, 2020
Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label studyJanet H Ford, Virginia L Stauffer, Peter McAllister, et al.
Pageof 57